Found: 88
Select item for more details and to access through your institution.
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patients.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01108-2
- By:
- Publication type:
- Article
Plasma ACE2 species are differentially altered in COVID-19 patients.
- Published in:
- FASEB Journal, 2021, v. 35, n. 8, p. 1, doi. 10.1096/fj.202100051R
- By:
- Publication type:
- Article
Synthetic standard aided quantification and structural characterization of amyloid-beta glycopeptides enriched from cerebrospinal fluid of Alzheimer's disease patients.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-41897-5
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 5, p. 543, doi. 10.1177/1352458512460603
- By:
- Publication type:
- Article
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0208-8
- By:
- Publication type:
- Article
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls.
- Published in:
- Alzheimer's Research & Therapy, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13195-015-0124-3
- By:
- Publication type:
- Article
Amyloid-β metabolism in Niemann-Pick C disease models and patients.
- Published in:
- Metabolic Brain Disease, 2012, v. 27, n. 4, p. 573, doi. 10.1007/s11011-012-9332-8
- By:
- Publication type:
- Article
Tau protein profiling in tauopathies: a human brain study.
- Published in:
- Molecular Neurodegeneration, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13024-024-00741-9
- By:
- Publication type:
- Article
Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Identification of neurotoxic cross-linked amyloid-β dimers in the Alzheimer's brain.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction: Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy.
- Published in:
- Annals of Neurology, 2023, v. 94, n. 1, p. 208, doi. 10.1002/ana.26675
- By:
- Publication type:
- Article
Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy.
- Published in:
- Annals of Neurology, 2023, v. 93, n. 6, p. 1173, doi. 10.1002/ana.26610
- By:
- Publication type:
- Article
Specific Mutations in the Cholesterol-Binding Site of APP Alter Its Processing and Favor the Production of Shorter, Less Toxic Aβ Peptides.
- Published in:
- Molecular Neurobiology, 2022, v. 59, n. 11, p. 7056, doi. 10.1007/s12035-022-03025-9
- By:
- Publication type:
- Article
Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome.
- Published in:
- Acta Neuropathologica, 2024, v. 148, n. 1, p. 1, doi. 10.1007/s00401-024-02756-4
- By:
- Publication type:
- Article
CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease.
- Published in:
- Acta Neuropathologica, 2024, v. 147, n. 1, p. 1, doi. 10.1007/s00401-023-02659-w
- By:
- Publication type:
- Article
Optimal blood tau species for the detection of Alzheimer’s disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study.
- Published in:
- Acta Neuropathologica, 2024, v. 147, n. 1, p. 1, doi. 10.1007/s00401-023-02660-3
- By:
- Publication type:
- Article
Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.
- Published in:
- Acta Neuropathologica, 2021, v. 141, n. 5, p. 709, doi. 10.1007/s00401-021-02275-6
- By:
- Publication type:
- Article
Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease.
- Published in:
- Acta Neuropathologica, 2019, v. 137, n. 2, p. 279, doi. 10.1007/s00401-018-1948-2
- By:
- Publication type:
- Article
The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease.
- Published in:
- Acta Neuropathologica, 2019, v. 137, n. 1, p. 89, doi. 10.1007/s00401-018-1910-3
- By:
- Publication type:
- Article
Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease.
- Published in:
- Acta Neuropathologica, 2010, v. 120, n. 2, p. 185, doi. 10.1007/s00401-010-0690-1
- By:
- Publication type:
- Article
P‐tau235: a novel biomarker for staging preclinical Alzheimer's disease.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 12, p. 1, doi. 10.15252/emmm.202115098
- By:
- Publication type:
- Article
Heteromers of amyloid precursor protein in cerebrospinal fluid.
- Published in:
- Molecular Neurodegeneration, 2015, v. 10, n. 1, p. 1, doi. 10.1186/1750-1326-10-2
- By:
- Publication type:
- Article
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease.
- Published in:
- Molecular Neurodegeneration, 2014, v. 9, n. 1, p. 161, doi. 10.1186/1750-1326-9-53
- By:
- Publication type:
- Article
Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry.
- Published in:
- Clinical Proteomics, 2016, v. 13, p. 1, doi. 10.1186/s12014-016-9104-2
- By:
- Publication type:
- Article
Effects of γ-Secretase Inhibition on the Amyloid β Isoform Pattern in a Mouse Model of Alzheimer’s Disease.
- Published in:
- Neurodegenerative Diseases, 2010, v. 6, n. 5/6, p. 258, doi. 10.1159/000264639
- By:
- Publication type:
- Article
Identification of Novel APP/Aβ Isoforms in Human Cerebrospinal Fluid.
- Published in:
- Neurodegenerative Diseases, 2009, v. 6, n. 3, p. 87, doi. 10.1159/000203774
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021, v. 13, n. 1, p. 1, doi. 10.1002/dad2.12179
- By:
- Publication type:
- Article
Identification of Novel α-Synuclein Isoforms in Human Brain Tissue by using an Online NanoLC-ESI-FTICR-MS Method.
- Published in:
- Neurochemical Research, 2011, v. 36, n. 11, p. 2029, doi. 10.1007/s11064-011-0527-x
- By:
- Publication type:
- Article
A novel proteomics assay allows parallel quantitation of a panel of synaptic proteins in human cerebrospinal fluid: Biomarkers (non‐neuroimaging) / novel biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042578
- By:
- Publication type:
- Article
Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains: Human neuropathology/amyloid.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042479
- By:
- Publication type:
- Article
P4‐531: CEREBROSPINAL FLUID APOLIPOPROTEIN E ISOFORM CONCENTRATIONS IN RELATION TO β‐AMYLOID POSITIVITY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1517, doi. 10.1016/j.jalz.2019.08.078
- By:
- Publication type:
- Article
P4‐519: MOLECULAR FORMS OF NEUROGRANIN IN CEREBROSPINAL FLUID.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1513, doi. 10.1016/j.jalz.2019.08.065
- By:
- Publication type:
- Article
P4‐135: NATIVE GEL OVERLAY WITH FRET SUBSTRATE AND MS OF IN‐GEL DIGESTED ACTIVE BANDS SHOW THAT CALPAIN‐2 IS RESPONSIBLE FOR TAU CLEAVAGE AT AMINO ACID 224.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1327, doi. 10.1016/j.jalz.2019.06.3796
- By:
- Publication type:
- Article
O1‐03‐06: PYROGLUTAMATION OF AβX‐42 AND Aβ1‐40 DEPOSITION UNDERLIE AMYLOID PLAQUE POLYMORPHISM IN PROGRESSING ALZHEIMER'S DISEASE PATHOLOGY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P200, doi. 10.1016/j.jalz.2019.06.4534
- By:
- Publication type:
- Article
P1‐217: PROTEOLYTIC PROCESSING OF THE SYNAPTIC ALZHEIMER BIOMARKER NEUROGRANIN BY CALPAIN I AND PROLYL ENDOPEPTIDASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P361, doi. 10.1016/j.jalz.2018.06.222
- By:
- Publication type:
- Article
NOVEL ASSAYS TO MONITOR Aβ PEPTIDES GENERATED BY THE ASPARAGATE ENDOPEPTIDASE AFTER INHIBITION OF BACE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1478, doi. 10.1016/j.jalz.2017.07.552
- By:
- Publication type:
- Article
N-TERMINAL FRAGMENT OF TAU: ASSAY DEVELOPMENT WITH IN-HOUSE CLEAVAGE-SPECIFIC ANTIBODY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P964, doi. 10.1016/j.jalz.2017.06.1294
- By:
- Publication type:
- Article
IS THE PRESUBICULUM PROTECTED FROM NEURODEGENERATIVE CHANGES? A PATHOLOGICAL AND BIOCHEMICAL INVESTIGATION.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P668, doi. 10.1016/j.jalz.2017.06.809
- By:
- Publication type:
- Article
NOVEL CSF FRAGMENTS OF TAU: CANDIDATE BIOMARKERS OF ALZHEIMER’S DISEASE AND TAUOPATHIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P706, doi. 10.1016/j.jalz.2017.06.898
- By:
- Publication type:
- Article
NOVEL METHOD FOR OLIGOMERIC Aβ DETECTION REVEALS INTRACELLULAR ACCUMULATION OF Aβ UPON LOW-DOSE TREATMENT WITH A GAMMA-SECRETASE INHIBITOR.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P314, doi. 10.1016/j.jalz.2017.06.254
- By:
- Publication type:
- Article
ANALYSIS OF NEW POTENTIAL CSF BIOMARKERS FOR ALZHEIMER’S DISEASE BY PARALLEL REACTION MONITORING MASS SPECTROMETRY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P352, doi. 10.1016/j.jalz.2017.06.284
- By:
- Publication type:
- Article
PRESYNAPTIC DEGRADATION IN ALZHEIMER’S DISEASE MEASURED BY NOVEL GAP-43 ELISA IN CSF.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1513, doi. 10.1016/j.jalz.2017.07.631
- By:
- Publication type:
- Article
The aqueous phase of Alzheimer's disease brain contains assemblies built from ∼4 and ∼7 kDa Aβ species.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 11, p. 1286, doi. 10.1016/j.jalz.2015.01.005
- By:
- Publication type:
- Article
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 10, p. 1180, doi. 10.1016/j.jalz.2014.10.009
- By:
- Publication type:
- Article
High resolution mass spectrometry parallel reaction monitoring multiplex assays of human CSF proteins using minimum sample preparation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, p. P795, doi. 10.1016/j.jalz.2014.05.1550
- By:
- Publication type:
- Article
The performance of Aβ5-X isoforms as novel pharmacodynamic markers of BACE1 inhibition
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Longitudinal measurements of cerebrospinal fluid biomarkers over four years in mild cognitive impairment
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Amyloid-related biomarkers for BACE1 inhibition in cell models of Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
The zebrafish brain proteome project
- Published in:
- 2009
- By:
- Publication type:
- Abstract
P3-071: Mass spectrometric characterization of tau in cerebrospinal fluid
- Published in:
- 2008
- By:
- Publication type:
- Abstract